Sort
64,565 grants matching “drug discovery”
Leadership, Planning and Evaluation
$616,942Steven E Artandi · Stanford University · P30 · FY2023 · CA
ICBG: "Training, Conservation and Drug Discovery using Panamanian Microorganisms
$616,936William H Gerwick · Smithsonian Institution · U01 · FY2011 · TW
ICBG: "Training, Conservation and Drug Discovery using Panamanian Microorganisms
$616,936William H Gerwick · Smithsonian Institution · U01 · FY2012 · TW
Development of an Efficient 18F labeling technology based on tetrazine trans-cyclooctene ligation
$616,880Zibo Li · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA
A Human-Centered Pharmacogenomic Screen of Metformin Action
$616,879Jose Carlos Florez · Massachusetts General Hospital · R01 · FY2014 · DK
Novel integrative imaging genetics analysis for Alzheimer's disease riskand progression
$616,832Yize Zhao · Yale University · R01 · FY2024 · AG
Autoantibodies Define Scleroderma Subgroups with Distinct Relationships to Cancer
$616,811Ami Aalok Shah · Johns Hopkins University · R01 · FY2021 · AR
Genetic and social determinants of pharmacological health outcomes in ancestrally diverse populations
$616,738Akinyemi Oni-Orisan · University Of California, San Francisco · R01 · FY2023 · HG
REGULATION OF LIPID METABOLISM IN BACTERIA
$616,721Charles O Rock · St. Jude Children'S Research Hospital · R37 · FY2007 · GM
Discovery Proteomics Core
$616,706Tukiet T Lam · Yale University · P30 · FY2016 · DA
Vaccina Virus DNA Topoisomerase
$616,688Stewart H Shuman · Sloan-Kettering Inst Can Research · R37 · FY2012 · GM
CAREER: A Comprehensive and Lightweight Framework for Transcriptome Analysis
$616,686Robert Patro · University Of Maryland, College Park · · FY2020 · CSE
Vaccina Virus DNA Topoisomerase
$616,686Stewart H Shuman · Sloan-Kettering Inst Can Research · R37 · FY2015 · GM
Vaccina Virus DNA Topoisomerase
$616,686Stewart H Shuman · Sloan-Kettering Inst Can Research · R37 · FY2014 · GM
Vaccina Virus DNA Topoisomerase
$616,686Stewart H Shuman · Sloan-Kettering Inst Can Research · R37 · FY2016 · GM
Frataxin deficiency as a cause of endothelial senescence in multiple subtypes of pulmonary hypertension
$616,679Stephen Y Chan · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · HL
Hit-to-lead optimization for sleeping sickness drug discovery
$616,674Michael P Pollastri · Northeastern University · R01 · FY2017 · AI
Core C Pharmacology
$616,666Veronique Dartois · Hackensack University Medical Center · U19 · FY2020 · AI
Targeting SARS-CoV-2 PLpro for COVID-19 treatment
$616,612Rui Xiong · University Of Arizona · R01 · FY2025 · AI
Molecular characterization of myeloma and related asymptomatic precursor states
$616,560Elizabeth E Brown · University Of Alabama At Birmingham · R01 · FY2015 · CA
Cell Morphology-guided, Scalable and Controllable Molecule Design via Generative AI
$616,523Yanjun Li · University Of Florida · R21 · FY2025 · EB
Integrative Modeling of HIV-Associated Neurocognitive Disorder in Human Brain Organoids
$616,363Bennett G Novitch · University Of California Los Angeles · R01 · FY2022 · DA
Integrative Modeling of HIV-Associated Neurocognitive Disorder in Human Brain Organoids
$616,363Bennett G Novitch · University Of California Los Angeles · R01 · FY2023 · DA
Integrative Modeling of HIV-Associated Neurocognitive Disorder in Human Brain Organoids
$616,363Bennett G Novitch · University Of California Los Angeles · R01 · FY2020 · DA
Integrative Modeling of HIV-Associated Neurocognitive Disorder in Human Brain Organoids
$616,363Bennett G Novitch · University Of California Los Angeles · R01 · FY2021 · DA